61 related articles for article (PubMed ID: 9927055)
21. Transduction and oncolytic profile of a potent replication-competent adenovirus 11p vector (RCAd11pGFP) in colon carcinoma cells.
Silver J; Mei YF
PLoS One; 2011 Mar; 6(3):e17532. PubMed ID: 21455297
[TBL] [Abstract][Full Text] [Related]
22. Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus.
Kubo S; Kawasaki Y; Yamaoka N; Tagawa M; Kasahara N; Terada N; Okamura H
J Gene Med; 2010 Aug; 12(8):681-92. PubMed ID: 20635326
[TBL] [Abstract][Full Text] [Related]
23. Oncolytic adenovirus mediated Survivin knockdown by RNA interference suppresses human colorectal carcinoma growth in vitro and in vivo.
Shen W; Wang CY; Wang XH; Fu ZX
J Exp Clin Cancer Res; 2009 Jun; 28(1):81. PubMed ID: 19527508
[TBL] [Abstract][Full Text] [Related]
24. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.
Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW
Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518
[TBL] [Abstract][Full Text] [Related]
25. Armed replicating adenoviruses for cancer virotherapy.
Cody JJ; Douglas JT
Cancer Gene Ther; 2009 Jun; 16(6):473-88. PubMed ID: 19197323
[TBL] [Abstract][Full Text] [Related]
26. Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumors.
Li HJ; Everts M; Yamamoto M; Curiel DT; Herschman HR
Cancer Res; 2009 Jan; 69(2):554-64. PubMed ID: 19147569
[TBL] [Abstract][Full Text] [Related]
27. PTD-mediated loading of tumor-seeking lymphocytes with prodrug-activating enzymes.
Yang Q; Larsen SK; Mi Z; Robbins PD; Basse PH
AAPS J; 2008 Dec; 10(4):614-21. PubMed ID: 19104945
[TBL] [Abstract][Full Text] [Related]
28. Cellular genetic tools to control oncolytic adenoviruses for virotherapy of cancer.
Nettelbeck DM
J Mol Med (Berl); 2008 Apr; 86(4):363-77. PubMed ID: 18214411
[TBL] [Abstract][Full Text] [Related]
29. Conditionally replicating adenoviruses for cancer treatment.
Jounaidi Y; Doloff JC; Waxman DJ
Curr Cancer Drug Targets; 2007 May; 7(3):285-301. PubMed ID: 17504125
[TBL] [Abstract][Full Text] [Related]
30. Evolving gene therapy approaches for osteosarcoma using viral vectors: review.
Witlox MA; Lamfers ML; Wuisman PI; Curiel DT; Siegal GP
Bone; 2007 Apr; 40(4):797-812. PubMed ID: 17189720
[TBL] [Abstract][Full Text] [Related]
31. Tissue inhibitor of metalloproteinases-2 improves antitumor efficacy of a replicating adenovirus in vivo.
Kim MH; Bodenstine TM; Sumerel LA; Rivera AA; Baker AH; Douglas JT
Cancer Biol Ther; 2006 Dec; 5(12):1647-53. PubMed ID: 17106248
[TBL] [Abstract][Full Text] [Related]
32. A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy.
Hakkarainen T; Hemminki A; Curiel DT; Wahlfors J
Int J Mol Med; 2006 Oct; 18(4):751-9. PubMed ID: 16964432
[TBL] [Abstract][Full Text] [Related]
33. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.
Jogler C; Hoffmann D; Theegarten D; Grunwald T; Uberla K; Wildner O
J Virol; 2006 Apr; 80(7):3549-58. PubMed ID: 16537623
[TBL] [Abstract][Full Text] [Related]
34. Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses.
Vecil GG; Lang FF
J Neurooncol; 2003 Dec; 65(3):237-46. PubMed ID: 14682374
[TBL] [Abstract][Full Text] [Related]
35. Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy.
Hu Y; Lee J; McCart JA; Xu H; Moss B; Alexander HR; Bartlett DL
J Virol; 2001 Nov; 75(21):10300-8. PubMed ID: 11581398
[TBL] [Abstract][Full Text] [Related]
36. Tissue-specific, tumor-selective, replication-competent adenovirus vector for cancer gene therapy.
Doronin K; Kuppuswamy M; Toth K; Tollefson AE; Krajcsi P; Krougliak V; Wold WS
J Virol; 2001 Apr; 75(7):3314-24. PubMed ID: 11238857
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy for brain tumors.
Bansal K; Engelhard HH
Curr Oncol Rep; 2000 Sep; 2(5):463-72. PubMed ID: 11122879
[TBL] [Abstract][Full Text] [Related]
38. Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.
Kurihara T; Brough DE; Kovesdi I; Kufe DW
J Clin Invest; 2000 Sep; 106(6):763-71. PubMed ID: 10995787
[TBL] [Abstract][Full Text] [Related]
39. Tumor-specific, replication-competent adenovirus vectors overexpressing the adenovirus death protein.
Doronin K; Toth K; Kuppuswamy M; Ward P; Tollefson AE; Wold WS
J Virol; 2000 Jul; 74(13):6147-55. PubMed ID: 10846098
[TBL] [Abstract][Full Text] [Related]
40. Gene delivery from replication-selective viruses: arming guided missiles in the war against cancer.
Hermiston T
J Clin Invest; 2000 May; 105(9):1169-72. PubMed ID: 10791988
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
